Multicenter, placebo‐controlled, double‐blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy‐induced nausea and vomiting in patients receiving highly emetogenic chemotherapy

BACKGROUND: The current randomized, double‐blind, phase 2 study assessed the efficacy and safety profile of a single intravenous administration of fosnetupitant, a neurokinin 1 receptor antagonist prodrug, for the prevention of chemotherapy‐induced nausea and vomiting in Japanese patients receiving...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer
Main Authors: Sugawara, Shunichi, Inui, Naoki, Kanehara, Masashi, Morise, Masahiro, Yoshimori, Kozo, Kumagai, Toru, Fukui, Tomoya, Minato, Koichi, Iwashima, Akira, Takeda, Yuichiro, Kubota, Kaoru, Saeki, Toshiaki, Tamura, Tomohide
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900104/
https://ncbi.nlm.nih.gov/pubmed/31381152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32429
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker